Salmonella is the most prevalent cause of bacterial foodborne illness in the United States, with nearly one-third of reported cases each year attributed to eggs and poultry.1
The responsibility of reducing the risk doesn’t fall solely to processing plants. Live-side solutions, such as Salmonella vaccines, help reduce Salmonella contamination brought to the processing plant.
Elanco initiated field research with an integrated poultry processor to study the effect of AviPro® Megan® Vac 1 and AviPro® Megan® Egg on reducing the prevalence of Salmonella in poultry products. Over two years, 3,875 samples were collected: 1,494 hot-rehang samples and 2,381part rinse samples.
The research found that administering Megan Egg to breeders and Megan Vac 1 to broilers resulted in a 43% reduction in the prevalence of Salmonella and reduced the combined prevalence of serotypes B and D by 26.3%.2
Megan Egg and Megan Vac 1 are live Typhimurium vaccines and are most effective on the higher-risk Salmonella B and D serogroups, which are difficult strains to manage with in-plant interventions.
Poultry processors and producers must have a comprehensive Salmonella vaccination plan to yield the best results and reduce Salmonella contamination entering the plant.
To learn more about Salmonella control, visit Salmonella 360.
The label contains complete use information, including cautions and warnings. Always read, understand and follow label and use directions.
1American Meat Science Association. Salmonella fact sheet.
2Elanco Animal Health. Data on File.